First 30 Days After a CADASIL Diagnosis

If a clinician just said CADASIL—or if a lab report named a NOTCH3 variant—you may feel like the floor moved.

That reaction is not overreacting. A rare genetic small-vessel disease diagnosis packs a lot into a few syllables: brain, inheritance, MRI, future. Some people go into research mode. Some go quiet. Some cry in the parking lot and then make dinner like nothing happened. All of those responses are human.

This post is not another explainer of what CADASIL is. For the science-in-plain-language overview, start with CADASIL, explained for families or the shorter literacy page, What is CADASIL?. The CADASIL hub maps the rest.

This post is a practical first-month checklist: what to gather, whom to ask, how to talk (gently) with family, and how to build a sustainable rhythm—without pretending there is a cure waiting in the next click.

What we can offer: education grounded in reputable sources (NIH/NINDS, NORD, GeneReviews, and major society statements) plus community orientation.
What we cannot offer: medical advice, a personalized prognosis, or a treatment plan. Use this with your care team. Read the disclaimer at the end.

You do not have to finish this month “caught up.” You only have to take the next clear step.

Days 1–7: Stabilize the chaos (care team, questions, records)

1. Name one coordinating clinician

Ask, explicitly: Who is the point person for CADASIL-related decisions—neurology, primary care, or a specialty clinic? Rare disease care often involves multiple offices. One named coordinator reduces the “everyone thought someone else was watching this” problem.

If your local neurologist is honest that CADASIL is outside their usual panel, that is not failure—it is useful information. Ask for a referral to a center or clinician experienced in genetic cerebral small-vessel disease, even if the first visit is telehealth or months out. Keep your local team in the loop for day-to-day needs.

2. Build a one-page medical snapshot

In the first week, create a simple document (phone note or paper) that travels with you:

Confirmed or suspected diagnosis wording (as written by the clinician)
Genetic result summary, if available (gene, variant classification if stated—e.g., pathogenic / likely pathogenic / VUS)
Key MRI dates and where images/reports live
Current medications and allergies
Stroke / TIA / migraine / mood history in plain dates
Family history highlights (who had early stroke, dementia, migraine with aura—without diagnosing relatives)

You are not writing a novel. You are building a tool so you stop retelling the whole story from scratch at every desk.

3. Request records before you need them urgently

Request, in writing if needed:

Neurology notes from the diagnostic visit
Genetic test report (the full lab PDF, not only a verbal summary)
MRI reports and information on how to obtain disks/portal access for outside review
Hospital discharge summaries for any stroke/TIA admissions

Portals close. Staff change. Having copies early is kindness to Future You.

4. Bring a short question list to the next neurology visit

Overwhelm makes brains blank in exam rooms. Write questions down. Adapt this starter list:

What in my / our loved one’s history and imaging supports CADASIL, and what else was considered?
Is the genetic result definitive, or do we need counseling / further testing (including, in selected cases, specialized skin biopsy when genetics are unclear)?
What symptoms should trigger an urgent call vs. 911?
What is our plan for migraine, mood, blood pressure, and other day-to-day risks—specific to this person?
Which medications or supplements should we not start or stop based on internet advice?
Should we involve a genetic counselor before anyone else in the family tests?
Are there reputable registries or trials we should know about (without pressure to enroll)?

Stroke readiness note: Public stroke education still applies—sudden face drooping, arm weakness, speech difficulty, or other abrupt neurologic change is an emergency. Call local emergency services. Acute treatment decisions belong to the treating stroke team and must account for individual imaging and risks. Do not invent a CADASIL-only protocol from a blog.

5. Protect the household’s nervous system

In week one, logistics matter more than mastery:

Sleep and food are medical infrastructure, not luxuries.
Limit doom-scrolling to a set window; prefer NINDS, NORD, GeneReviews, and our hub over unmoderated threads.
Tell one trusted person what happened—even if you are not ready for a family-wide announcement.
If mood crashes into hopelessness, inability to function, or thoughts of self-harm, that is a clinical and crisis priority, not a personality flaw. In the U.S., call or text 988 for the Suicide & Crisis Lifeline right away—or 911 / local emergency services if there is immediate danger. Do not wait on a Foundation inbox for that. The Goodyear Foundation is not a crisis hotline.

Sources for this section’s clinical framing: NINDS — CADASIL; GeneReviews — Diagnosis / Management; NORD — Diagnosis / Therapies.

Weeks 2–3: Genetics, gentle family conversations, and support scaffolding

6. Schedule genetic counseling (even if testing already happened)

Genetic counseling is not a formality and not only for “before” testing. Counselors help families:

Interpret what a NOTCH3 result does—and does not—predict for any one person
Understand autosomal dominant inheritance (each child of a person with a disease-causing variant has a 50% chance of inheriting it; sons and daughters equally)
Decide whether, when, and how relatives pursue testing
Navigate variants of uncertain significance, if that is your situation
Plan for insurance, privacy, and emotional fallout of predictive testing

Hard but important: Predictive testing of healthy adult relatives should follow genetic counseling—not a hallway conversation or a direct-to-consumer impulse. Testing children for this adult-onset condition is generally deferred until adulthood (or until they can consent), except in uncommon situations a genetics team identifies. GeneReviews and clinical genetics practice treat counseling as standard of care around these decisions.

If genetics are inconclusive, clinicians sometimes consider specialized skin biopsy looking for characteristic vessel findings. That path is selected, not automatic for every newly diagnosed person.

7. Plan family conversations like you would plan a hard meeting

You are allowed to wait. You are allowed to share with one sibling and not another. You are allowed to say, “I have news about a genetic condition in our family; I need a week before I can talk details.”

When you are ready, gentler openings often work better than a genetics lecture:

“I learned something about my health that can run in families. I’m still absorbing it.”
“There is a gene involved. It does not mean everyone who inherits it has the same story.”
“I’m sharing information, not asking anyone to test today.”
“Here is a short plain-language page if you want facts without me as the messenger”: What is CADASIL?

Expect mixed reactions: fear, minimization, research spirals, old family conflicts resurfacing. None of that means you explained it wrong. In small towns—including places like Sheridan—privacy is a real calculation; choose channels accordingly.

8. Put mental health on the care map early

Depression, anxiety, apathy, and other psychiatric symptoms are repeatedly described in CADASIL references—not as weakness, but as part of how this disease can affect the brain and a family’s load. Ask your clinicians about screening and treatment options. Caregivers deserve their own support, too—without earning it through collapse. Watching someone you love absorb a rare diagnosis is its own injury; asking for help early is not failing them.

Peer connection can reduce isolation when it is clearly peer support—not therapy and not medical advice. As The Goodyear Foundation builds community offerings, we will keep that lane clarity visible.

9. Start a “village list,” not a hero plan

Write down:

Who can drive to appointments
Who can sit through a genetics session and take notes
Who should not be asked for medical opinions (loving people can still be unsafe advice-givers)
Which patient organizations’ pages you trust enough to bookmark (NORD, established CADASIL nonprofits, ClinicalTrials.gov for research browsing)

Sources: GeneReviews — Inheritance / Genetic Counseling / Management; MedlinePlus Genetics — CADASIL; NORD — Causes / Standard Therapies.

Week 4: Routines, risk-factor basics (honestly hedged), and community

By week four, the goal is not perfection. It is a repeatable rhythm that does not require adrenaline.

10. Build a sustainable week, not a medical bootcamp

Useful routines many families settle into:

One recurring slot to refill meds, check portals, and update the one-page snapshot
A written migraine / mood / “call the clinic” plan posted where caregivers can find it
Movement, sleep, and meals treated as non-negotiable supports—not as moral tests
A calendar reminder for the next neurology or counseling follow-up so the first month’s momentum does not evaporate

If cognitive changes or apathy are part of the picture, shrink the routine until it is actually doable. Apathy in CADASIL can be a brain symptom, not laziness or “not caring enough.” Small and consistent beats ambitious and abandoned.

11. Risk-factor basics—without false promises

Authoritative sources agree on a difficult pair of truths:

There is currently no cure and no proven therapy that stops CADASIL.
Supportive care and vascular risk management still matter—because additional, preventable injury on top of a genetic small-vessel disease helps no one.

NINDS notes that people with CADASIL should take steps to prevent stroke, including controlling high blood pressure, cholesterol, and glucose as appropriate, and that people with CADASIL should not smoke. NORD similarly emphasizes treating factors that further damage vessels and abstaining from smoking. The American Heart Association’s 2023 scientific statement on inherited CNS small-vessel diseases (using CADASIL as the example) recommends intensive blood pressure control and avoiding tobacco, citing observational links between these factors and worse outcomes—while also acknowledging the lack of randomized trials proving that risk-factor management changes CADASIL-specific progression.

Foundation wording (aligned with Synapse Blog 1 clearance): Not smoking and treating blood pressure are strongly recommended to reduce added stroke risk. They are important; they are not a proven way to stop CADASIL or guarantee a slower course.

Some migraine medicines that narrow blood vessels (including certain triptans and ergot-type drugs) are often avoided or used only with extra caution in CADASIL; evidence is limited and practice varies. Do not start or stop these based on this article—ask a neurologist who knows CADASIL.

Daily antiplatelet pills for preventing a first stroke in CADASIL are unproven. Even after a prior stroke or TIA, antiplatelet choices are individualized—CADASIL-specific benefit is uncertain, and bleeding risk on brain MRI matters. Blood thinners (anticoagulants) are generally considered only when there is a separate reason (such as atrial fibrillation). Discuss with a neurologist who knows CADASIL; do not copy online regimens. Emergency clot-busting treatment for acute stroke is a stroke-team decision based on individual criteria—not something to self-direct.

12. Orient to research without getting scavenged by hype

If energy allows this month:

Ask your neurologist which registries or observational studies are reputable
Browse ClinicalTrials.gov with a clinician’s help interpreting eligibility
Be skeptical of marketing that bolts “CADASIL” onto unrelated stem-cell or supplement menus

Hope that is honest looks like: research is active; natural-history and biomarker work make future trials possible; your job this month is care and clarity, not becoming a full-time scientist.

13. Reassess support needs before the adrenaline fades

Week four is when many households realize the sprint is over and the marathon began. Ask:

Do we need counseling (individual, couples, or family)?
Is work/school paperwork (FMLA, accommodations) due?
Who is burning out quietly?
What is one thing we can put down?

Sources: NINDS — Treating CADASIL; NORD — Standard Therapies; AHA 2023 Scientific Statement; GeneReviews — Management.

Soft CTA: resources, Harbor, and Follow the Build

You do not have to carry a rare diagnosis with only search results for company.

Start with education we already publish:

About patient services: The Goodyear Foundation is building Harbor-aligned patient and family resource navigation—the practical “who do I call / what exists near me” layer that education alone cannot replace. That work is coming online carefully. We will not pretend a full intake desk, wait-time promise, or case-management portal exists before it does. When pathways open, we will say so plainly on the site and through Follow the Build updates.

Stay connected while we build: We are pursuing 501(c)(3) status and cannot accept donations yet. If you want program updates—and a note the moment we can legally receive gifts—Follow the Build at Get involved.

The Goodyear Foundation is a Sheridan, Wyoming nonprofit focused on CADASIL families and broader community wellness. We are not the corporate foundation of The Goodyear Tire & Rubber Company.

The hardest sentence already landed. You do not have to turn it into a mastery project this month. The next thirty days are about building a care system that can hold you—imperfectly, honestly, and with company.

Sources

National Institute of Neurological Disorders and Stroke (NINDS). CADASIL. https://www.ninds.nih.gov/health-information/disorders/cadasil
National Organization for Rare Disorders (NORD). CADASIL. https://rarediseases.org/rare-diseases/cadasil/
Hack RJ, Rutten J, Lesnik Oberstein SAJ. CADASIL. GeneReviews®. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK1500/
MedlinePlus Genetics. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. https://medlineplus.gov/genetics/condition/cerebral-autosomal-dominant-arteriopathy-with-subcortical-infarcts-and-leukoencephalopathy/
Meschia JF, et al. Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association. Stroke. 2023. https://www.ahajournals.org/doi/10.1161/STR.0000000000000444 · https://doi.org/10.1161/str.0000000000000444
Mancuso M, et al. Monogenic cerebral small‐vessel diseases: diagnosis and therapy. European Academy of Neurology consensus. Eur J Neurol. 2020. https://doi.org/10.1111/ene.14183
ClinicalTrials.gov — search “CADASIL”. https://clinicaltrials.gov/

Medical disclaimer

This article is for education and community support only. It is not medical advice, diagnosis, or treatment. CADASIL care decisions—including genetic testing, imaging, migraine medicines, blood thinners, acute stroke care, mental-health treatment, and research participation—must be made with qualified clinicians who know your (or your loved one’s) full history. Do not start, stop, or change any medication based on this page. If you are experiencing stroke warning signs (face drooping, arm weakness, speech difficulty, sudden severe neurologic symptoms), call emergency services immediately. If you are in emotional crisis or having thoughts of self-harm, contact 988 (U.S.) or local emergency services.

The Goodyear Foundation (Sheridan, WY) provides information to help families ask better questions and find community orientation. We do not replace your medical team. Content is drafted against reputable sources and requires Synapse (medical) and Solace (trauma-informed) review before publication; it may be updated as science and guidance evolve. Synapse + Solace cleared September 2026. Published with Dalton go-live approval.

© The Goodyear Foundation — Communications (Cadence). Distinct from The Goodyear Tire & Rubber Company and any related corporate foundations.

What to Do in the First 30 Days After a CADASIL Diagnosis